This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Orthopedic bone graft developer Cerapedics Inc. has raised $19mm through its Series C financing round led by first-time investors MedImmune Ventures (adds a board member) and CVF LLC, which were joined by former backers OrbiMed Advisors and NGN Capital, and one undisclosed investor. The money will fund the ongoing IDE trial in the US of its i-FACTOR peptide-enhanced bone graft for cervical spine applications and to prep for the eventual commercialization. Funds will also support development of next-generation products and ex-US sales and marketing activities of i-FACTOR.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?